Verastem (VSTM) Operating Leases (2019 - 2026)
Verastem's (VSTM) quarterly Operating Leases came in at $2.3 million in Q1 2026, up 79.53% year-on-year from $1.3 million in Q1 2025, and up 332.9% quarter-over-quarter from $535000.0 in Q4 2025.
Verastem (VSTM) Operating Leases (2019 - 2026) Analysis & Trends
Verastem's Operating Leases history runs 8 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 79.53% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 79.53% increase from a year earlier, with the FY2025 full-year figure at $535000.0, changed 0.0% from the prior year.
- Operating Leases rose to $2.3 million in Q1 2026 per VSTM's latest filing, from $535000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $2.6 million in Q2 2022 and bottomed at $530000.0 in Q4 2023.
- The 5-year median for Operating Leases is $1.3 million (2024), against an average of $1.4 million.
- Across the five-year window, Operating Leases slumped 64.67% in 2023 and surged 79.53% in 2026, its largest moves.
- Year by year, Operating Leases stood at $1.5 million in 2022, then sank by 64.67% to $530000.0 in 2023, then increased by 0.94% to $535000.0 in 2024, then changed by 0.0% to $535000.0 in 2025, then jumped by 332.9% to $2.3 million in 2026.
- Per Business Quant, the three latest VSTM Operating Leases figures stand at $2.3 million (Q1 2026), $535000.0 (Q4 2025), and $800000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn |
| 10 | Verastem | 615.80 Mn | 417.97 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.32 Mn |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 535,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 530,000.00 |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 2.44 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 2.26 Mn |
| Sep 30, 2021 | 3.10 Mn |
| Jun 30, 2021 | 2.62 Mn |